BIOREGENX, INC. (BRGX) Operating income 2021–2025
BIOREGENX, INC. (BRGX) annual operating income history from SEC filings — each fiscal year as reported.
-$1.2MFY2025 · since FY2021: -$165,118 → -$1.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.2M | +94.5% |
| FY2024 | -$22.8M | -567.8% |
| FY2023 | -$3.4M | -4253.1% |
| FY2022 | -$78,308 | +52.6% |
| FY2021 | -$165,118 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BRGX financial trends
BRGX RevenueBRGX Net incomeBRGX Net marginBRGX Gross profitBRGX Gross marginBRGX Operating marginBRGX Operating cash flowBRGX Free cash flowBRGX Capital expendituresBRGX Return on equityBRGX Stock buybacksBRGX Dividends paidBRGX Total assetsBRGX Total liabilitiesBRGX Shareholders’ equityBRGX overview →